Covid-19, ACE2, RAASi

Episodes 1-4 of 4

• 

  RestartResume

  COVID-19, ACE2 and RAAS inhibition

  RestartResume

  COVID-19, ACE2 and RAAS inhibition

  Covid-19, ACE2, RAASi

  COVID-19, ACE2 and RAAS inhibition

  • 

    

    Profs. John Deanfield

• 

  RestartResume

  COVID-19, ACE2 and RAASi - a scientific perspective

  RestartResume

  COVID-19, ACE2 and RAASi - a scientific perspective

  Covid-19, ACE2, RAASi

  COVID-19, ACE2 and RAASi - a scientific perspective

  • 

    

    Prof. Jan Danser, PhD

• 

  RestartResume

  A clinical perspective on COVID-19, ACE2 and RAAS inhibition

  RestartResume

  A clinical perspective on COVID-19, ACE2 and RAAS inhibition

  Covid-19, ACE2, RAASi

  A clinical perspective on COVID-19, ACE2 and RAAS inhibition

  • 

    

    Prof. Murray Epstein, MD

• 

  RestartResume

  COVID-19, ACE2 and RAAS inhibition: What are the implications for practice?

  RestartResume

  COVID-19, ACE2 and RAAS inhibition: What are the implications for practice?

  Covid-19, ACE2, RAASi

  COVID-19, ACE2 and RAAS inhibition: What are the implications for practice?

  • 

    

    Profs. John Deanfield